Manufacturer record
Candour Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Candour Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between April 2025 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CT250131A, Atorvastatin Tablets IP 10mg (exp Apr 2027). DTL, Chennai-06 (state lab) found it not of standard quality: Dissolution. Listed in the February 2026 alert.
Records by type
7 records linked to Candour Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Atorvastatin Tablets IP 10mg | Batch CT250131AMfg May 2025 · Exp Apr 2027 | DissolutionDissolution | DTL, Chennai-06State lab | Feb 2026 |
| Co-Trimoxazole Oral Suspension IP | Batch CL250256AMfg Sep 2025 · Exp Aug 2027 | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test of Total microbial count, Total yeast and mould countMicrobial limits | RDTL, ChandigarhCDSCO lab | Jan 2026 |
| Co-Trimoxazole Oral Suspension IP | Batch CL250267AMfg Sep 2025 · Exp Aug 2027 | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test of Total microbial count, Total yeast and mould countMicrobial limits | RDTL, ChandigarhCDSCO lab | Jan 2026 |
| Atorvastatin Tablets IP 10mg | Batch CT240238AMfg Jul 2024 · Exp Jun 2026 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Oct 2025 |
| Aluminium Hydroxide, Magnesium Hydroxide, Dimethicone & Oxethazine Suspension) | Batch CL240052AMfg Mar 2024 · Exp Feb 2026 | Assay for Dried Aluminium HydroxideAssay | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Atorvastatin Tablets IP 10mg | Batch CT240237AMfg Jul 2024 · Exp Jun 2025 | Sample does not conform to IP specification for Atorvastatin Tablets with respect to DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | May 2025 |
| Atorvastatin Tablets IP 10mg | Batch CT240246AMfg Jul 2024 · Exp Jun 2026 | Sample does not conform to IP specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab | Apr 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.